Introduction {#s1}
============

Noroviruses, members of the virus family *Caliciviridae*, are ubiquitous enteric viruses found in a broad range of animal species, including mice [@pone.0021435-Green1]. In humans, they are associated with nausea, vomiting, diarrhea, and fever that characteristically last approximately 24--48 hours. They are transmitted via person-to-person contact, or by exposure to contaminated food or water. Outbreaks often occur in settings such as nursing homes and cruise ships, where close contact allows for easy spread of the virus. Long-term illness and shedding of noroviruses have been reported in immunocompromised individuals [@pone.0021435-Kaufman1]. The approximately 7.6 kb positive-sense, single-stranded RNA genome of norovirus is organized into three major open-reading frames (ORFs): ORF1 encodes a large polyprotein that is cleaved into nonstructural precursors and proteins involved in viral replication; ORF2 encodes the major capsid protein, VP1; and ORF3 encodes a minor structural protein of the virion, VP2 [@pone.0021435-Glass1], [@pone.0021435-Jiang1], [@pone.0021435-Lambden1], [@pone.0021435-Sosnovtsev1]. In murine norovirus (MNV) strains [@pone.0021435-Karst1], an additional ORF4 has been described that encodes a protein of unknown function [@pone.0021435-Thackray1]. Noroviruses have been divided into five distinct genogroups (GI--GV) [@pone.0021435-Zheng1], with human pathogens belonging to GI, GII, and GIV. The bovine and murine noroviruses detected thus far belong to GIII and GV, respectively. Although genetically distinct from the human noroviruses, the murine noroviruses have emerged as an important model in the study of norovirus biology and replication because, in contrast to the human pathogens, an efficient cell culture system is available [@pone.0021435-Wobus1], [@pone.0021435-Wobus2].

The discovery of the first MNV strain, designated MNV-1, in mice within a U.S. university research facility [@pone.0021435-Karst1] led to the development of antibody detection assays that quickly showed serologic evidence for a widespread distribution of this virus in laboratory mice [@pone.0021435-Hsu1]. Although most mice infected with MNV appear healthy, the viruses have been associated with severe systemic illness and death in certain genetically engineered mice lacking an intact innate immune system such as STAT1^−/−^ mice [@pone.0021435-Karst1]. The MNV strains characterized thus far have formed a highly related single genotype within GV, whether associated with asymptomatic infection or disease [@pone.0021435-Thackray1], but recombination events between viruses have been proposed [@pone.0021435-Muller1]. At our research institute, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), U.S., serologic evidence for MNV infection was found in several "sentinel" mice in various animal rooms [@pone.0021435-Ward1], [@pone.0021435-Perdue1], which prompted us to examine the molecular epidemiology of MNV within our animal facilities. We isolated murine noroviruses in cell culture from ten NIH mice and the genomes of these viruses were sequenced. The MNV strains characterized within each NIAID animal facility were distinct from those in other facilities of the institute, suggesting the introduction of the virus into each facility from a separate source. However, the NIH MNV strains showed marked overall genetic relatedness with other murine norovirus strains detected thus far.

Results {#s2}
=======

By serologic screening of sentinel mice housed in several NIAID animal facilities, we found evidence initially for norovirus infection, and in addition, we were able to detect the virus by RT-PCR in representative mice [@pone.0021435-Perdue1]. This study focused on the further characterization of MNV strains isolated from mice housed in three of the animal facilities ([Table 1](#pone-0021435-t001){ref-type="table"}). While all facilities housed mice from the same commercial vendors, each facility also housed mice received from separate non-commercial sources. Ten MNV strains (designated as the NIH strains) were isolated following passage in RAW264.7 cells, and their full-length genomes were sequenced. The genomes were similar in length (7382 or 7383 nt) and organized into three major open reading frames (ORFs): ORF1 (nt 6--5069) encoding the nonstructural polyprotein, ORF2 (nt 5056--6681) encoding the major capsid protein, VP1, and ORF3 (nt 6681--7307) encoding the minor capsid protein, VP2 ([Figure 1](#pone-0021435-g001){ref-type="fig"}). In addition, the genomes contained a predicted conserved fourth ORF (ORF4) spanning nt 5069--5710 that would encode a putative protein of 23.6 kDa [@pone.0021435-Thackray1].

![Sequence analysis of NIH MNV strains.\
Genome organization of prototype strain MNV-1 [@pone.0021435-Karst1] and ORF1 polyprotein cleavage sites [@pone.0021435-Sosnovtsev1] in comparison with the predicted cleavage sites in the ORF1 polyprotein of the NIH murine norovirus strains. Dipeptide recognition sites that differ from MNV-1 are indicated in bold type.](pone.0021435.g001){#pone-0021435-g001}

10.1371/journal.pone.0021435.t001

###### Murine norovirus strains isolated from NIH mice.

![](pone.0021435.t001){#pone-0021435-t001-1}

  Strain Designation             NIH Facility       Mouse       Specimen     Passage (P)
  ----------------------------- -------------- --------------- ---------- ------------------
  Mu/NoV/GV/NIH- 2409/2005/US        B14           RAG2−/−        MLN      P0, P1, P2, 3xPP
  Mu/NoV/GV/NIH -2410/2005/US        B14           RAG2−/−        MLN             P3
  Mu/NoV/GV/NIH- 2411/2005/US        B14           RAG2−/−        MLN             P3
  Mu/NoV/GV/NIH- 2747/2005/US        B14           RAG2−/−        MLN             P3
  Mu/NoV/GV/NIH- 2750/2005/US        B14           RAG2−/−        MLN             P3
  Mu/NoV/GV/NIH -4421/2005/US        B14           RAG2−/−      Duodenum          P3
  Mu/NoV/GV/NIH -4428/2005/US        B14           RAG2−/−      Duodenum          P3
  Mu/NoV/GV/NIH-4431/2005/US         B14           RAG2−/−      Duodenum          P4
  Mu/NoV/GV/NIH -A114/2006/US         TB        Swiss Webster    Fecal            P7
  Mu/NoV/GV/NIH-D220/2007/US         B50        Swiss Webster    Fecal            P2

\*Passage (P) number of virus in RAW264.7 cells at which genome sequence was determined as described in text.

Comparison of the nucleotide sequences showed a close genetic relationship among the NIH MNV strains, with a range of 87.2--99.7% overall nucleotide identity. The nucleotide identities with the prototype strain, MNV-1, ranged from 87.4--89.1%, and with all other full-length MNV sequences available in GenBank, the identities ranged from 87.4--99%. Comparison of the deduced amino acid sequences among the NIH strains showed that the proteinase was the most highly conserved protein (approximately 97% similarity), while the VP1 (major capsid protein) showed the most variability (as low as 89.6% similarity). Analysis of the MNV-1 VP1 capsid protein showed that the shell (S) region of the capsid protein (amino acid residues 49 to 218) was 100% conserved among the NIH MNV strains while the protruding (P) region (amino acids 229 to 537) was most variable, consistent with data reported for other highly-related murine noroviruses [@pone.0021435-Thackray1]. The P2 domain (amino acids 278--415) within the P region is exposed predominantly on the surface of the virion and has been proposed as the major site of immune pressure and receptor binding for calicivirus virions [@pone.0021435-Tan1]. Consistent with this, passage of the virulent MNV-1 strain in cell culture yielded virus in which lysine was changed to glutamic acid at position 296 in the P2 domain. This single amino acid substitution resulted in loss of virulence of the MNV-1 strain in STAT1-deficient mice (17). Of interest, a glutamic acid residue at position 296 was conserved in the cell-culture adapted NIH MNV strains in this study, as well as the NIH-2409 virus prior to adaptation (data not shown) [@pone.0021435-Bailey1]. A leucine residue at position 386 involved in the formation of a neutralization epitope in MNV-1 [@pone.0021435-Lochridge1] was conserved in the P2 domain of the NIH MNV strains (data not shown).

The replication strategy for murine norovirus involves the proteolytic processing of the ORF1 polyprotein into several nonstructural proteins by the virus-encoded cysteine proteinase (Pro). The proteinase mediates five cleavages at dipeptide sites ^341^E/G^342^, ^705^Q/N^706^, ^870^E/G^871^, ^994^E/A^995^, and ^1177^Q/G^1178^ to produce six proteins: NS1-2 (Nterm), NS3 (NTPase), NS4 (p18), NS5 (VPg), NS6 (Pro) and NS7 (Pol) [@pone.0021435-Sosnovtsev1]. Alignment of the deduced ORF1 polyprotein sequences of the NIH MNV strains with that of MNV-1 showed that these dipeptide cleavage sites were conserved in location, but with some minor variation in the P1′ positions at amino acid residues 706 and 871 ([Figure 1](#pone-0021435-g001){ref-type="fig"}).

A phylogenetic analysis of the complete genome sequences of the NIH MNV strains was performed to compare their relatedness with that of other murine noroviruses ([Figure 2](#pone-0021435-g002){ref-type="fig"}). The NIH strains clustered with Genogroup V murine noroviruses, but did not share complete identity with other strains reported thus far. Eight of the strains formed a distinct monophyletic group (NIH- 4421, 2747, 2409, 2411, 2410, 2750, 4428, and 4431, with nucleotide variation not exceeding 1%). Strain NIH-A114 did not cluster with other viruses and formed a distinct branch. Strain NIH-D220 clustered most closely with a phylogenetic group that included several Charles River (CR) and Washington University (WU) strains. The three genetic groupings of the NIH strains corresponded to their isolation from three distinct animal facilities in the institute at different times ([Table 1](#pone-0021435-t001){ref-type="table"}).

![Phylogenetic analysis of NIH MNV viral genomes in comparison with representative viruses previously published.\
Phylogenetic relationships were inferred using Neighbor-joining method, with the evolutionary distances computed by the Tamura-Nei method. The statistical support for tree nodes was evaluated by bootstrap analysis (500 replicates) and values higher than 65 are shown above the corresponding branches. The strains in this analysis and their GenBank accession numbers are shown in the Supplemental Table ([Table S1](#pone.0021435.s001){ref-type="supplementary-material"}).](pone.0021435.g002){#pone-0021435-g002}

A previous study had identified amino acid substitutions in the NS4 and VP1 proteins that emerged during cell-culture passage of the MNV-1 strain. In this study, we followed the evolution of MNV NIH-2409 during cell culture passage to examine whether similar substitutions occurred. Strain NIH-2409 was isolated from a RAG2^−/−^ mouse in a facility (B14) that has operated for more than 20 years, and that accepts vendor animals and transfer animals from within NIH as well as imported animals. The mesenteric lymph node tissue was homogenized and added to a monolayer of RAW264.7 cells and incubated for 7 days. There was no visible cytopathic effect (CPE) in RAW264.7 cells following the initial 7-day infection period. However, an immunofluorescence assay showed the presence of occasional cells with a perinuclear, localized area of positive reactivity with the MNV-1-specific antibodies (as indicated by arrows in [Figure 3A](#pone-0021435-g003){ref-type="fig"}) that was not present in the mock-infected RAW264.7 cells ([Figure 3B](#pone-0021435-g003){ref-type="fig"}). The passage 1 (P1) material was added to a new monolayer and the visible CPE increased with each subsequent cell passage. After three passages, the material was subjected to plaque purification, and small plaques were observed ([Figure 3C](#pone-0021435-g003){ref-type="fig"}). Following two additional rounds of plaque purification (selecting large plaques), the plaque morphology resembled MNV-1 ([Figure 3D](#pone-0021435-g003){ref-type="fig"}).

![Serial passage of MNV NIH-2409 in RAW264.7 cells.\
**A.** Immunofluorescence assay of RAW264.7 cells inoculated directly with a lymph node homogenate from mouse. Medium was removed after 7 days, cells were fixed with methanol, and viral antigen expression was detected with anti-MNV-1 VP1 serum. Representative positive MNV antigen expression is indicated by white arrows. **B.** Mock-infected RAW264.7 cells incubated with same serum. **C.** First plaque purification of NIH MNV-2409 following P3 in RAW264.7 cells as described in [Material and Methods](#s4){ref-type="sec"}. **D.** Plaque morphology after two additional plaque purifications in RAW264.7 cells (3XPP virus stock).](pone.0021435.g003){#pone-0021435-g003}

The "consensus sequence" of the genome of the virus in the original MLN specimen (P0) was determined by the direct sequencing of RT-PCR products that spanned the genome. Only a few nucleotide changes were observed between the first two serial passages (P1 and P2) and after three rounds of plaque purification (3xPP), consistent with previous studies of MNV-1 [@pone.0021435-Wobus2] ([Table 2](#pone-0021435-t002){ref-type="table"}). At nucleotide position 2166, a mixed population was detected that would result in either a serine or alanine at amino acid residue 721 in the NS4 region of the ORF1 polyprotein. Following three rounds of plaque purification of P3, an alanine became the predominant sequence at position 721. Of note, no adaptive amino acid mutations were observed in the VP1 (capsid) protein for this strain.

10.1371/journal.pone.0021435.t002

###### Sequence analysis of viral genomes during passage of MNV NIH-2409 in cell culture.

![](pone.0021435.t002){#pone-0021435-t002-2}

  Open Reading Frame (ORF)    Protein   Genomic Position of Nucleotide   Position of Amino Acid   Amino Acid   2409 Lymph Node (Pass 0)        2409 Pass 1             2409 Pass 2        2409 Pass 3 after plaque purification (3xPP)
  -------------------------- --------- -------------------------------- ------------------------ ------------ -------------------------- ----------------------- ----------------------- ----------------------------------------------
  ORF1                         NS1-2                 188                           61                Ala              GC[A]{.ul}          GC[A]{.ul}/GC[G]{.ul}   GC[G]{.ul}/GC[A]{.ul}                    GC[A]{.ul}
                               NS1-2                 320                          105                Ala              GC[C]{.ul}               GC[T]{.ul}              GC[T]{.ul}                          GC[C]{.ul}
                               NS1-2                 629                          208                Pro              CC[C]{.ul}               CC[T]{.ul}              CC[T]{.ul}                          CC[C]{.ul}
                                NS3                  1469                         488                Arg        CG[T]{.ul}/CG[C]{.ul}        CGC/CG[T]{.ul}          CGC/CG[T]{.ul}                        CG[C]{.ul}
                                NS3                  1487                         494                Arg        CG[G]{.ul}/CG[A]{.ul}     CG[A]{.ul}/CG[G]{.ul}   CG[A]{.ul}/CG[G]{.ul}                    CG[A]{.ul}
                                NS3                  1817                         604                Thr        AC[T]{.ul}/AC[C]{.ul}     AC[C]{.ul}/AC[T]{.ul}   AC[C]{.ul}/AC[T]{.ul}                    AC[C]{.ul}
                                NS3                  2081                         692                Val        GT[C]{.ul}/GT[T]{.ul}     GT[T]{.ul}/GT[C]{.ul}   GT[C]{.ul}/GT[T]{.ul}                    GT[C]{.ul}
                                NS4                  2166                         721              Ser→Ala      [T]{.ul}CC/[G]{.ul}CC     [G]{.ul}CC/[T]{.ul}CC   [T]{.ul}CC/[G]{.ul}CC                    [G]{.ul}CC
                                NS4                  2495                         830                Tyr              TA[C]{.ul}          TA[T]{.ul}/TA[C]{.ul}   TA[C]{.ul}/TA[T]{.ul}                    TA[T]{.ul}
                                NS4                  2531                         842                Tyr              TA[C]{.ul}          TA[T]{.ul}/TA[C]{.ul}   TA[C]{.ul}/TA[T]{.ul}                    TA[C]{.ul}
                                NS4                  2543                         846                Gly        GG[T]{.ul}/GG[C]{.ul}     GG[T]{.ul}/GG[C]{.ul}   GG[T]{.ul}/GG[C]{.ul}                    GG[T]{.ul}
                                NS7                  3803                         1266               Val        GT[T]{.ul}/GT[C]{.ul}     GT[C]{.ul}/GT[T]{.ul}   GT[C]{.ul}/GT[G]{.ul}                    GT[C]{.ul}
                                NS7                  3809                         1268               Asp        GA[T]{.ul}/GA[C]{.ul}     GA[T]{.ul}/GA[C]{.ul}   GA[T]{.ul}/GA[C]{.ul}                    GA[C]{.ul}
                                NS7                  4151                         1382               Phe        TT[C]{.ul}/TT[T]{.ul}     TT[C]{.ul}/TT[T]{.ul}   TT[T]{.ul}/TT[C]{.ul}                    TT[C]{.ul}
  ORF2                          VP1                  5481                         142                Thr              AC[A]{.ul}          AC[G]{.ul}/AC[A]{.ul}   AC[A]{.ul}/AC[G]{.ul}                    AC[G]{.ul}
                                VP1                  5892                         279                Thr        AC[G]{.ul}/AC[C]{.ul}          AC[G]{.ul}              AC[G]{.ul}                          AC[G]{.ul}
                                VP1                  5904                         283                Gly        GG[C]{.ul}/GG[T]{.ul}          GG[C]{.ul}              GG[C]{.ul}                          GG[C]{.ul}
                                VP1                  6550                         499                Leu              [T]{.ul}TG          [C]{.ul}TG/[T]{.ul}TG   [T]{.ul}TG/[C]{.ul}TG                    [C]{.ul}TG

Note: Positions with variation in sequence are underlined.

Discussion {#s3}
==========

Murine noroviruses are associated with asymptomatic infection and shedding in many mouse strains (both normal and genetically-modified), making the viruses difficult to detect in animals without active screening [@pone.0021435-Muller1]. We investigated the characteristics of several murine norovirus strains within our research institute (NIAID) in order to gain insight into norovirus diversity and natural history within a single setting. A real-time qRT-PCR assay [@pone.0021435-Ammann1] that readily detects MNV strains in mice housed in the NIAID animal facilities in Hamilton, Montana (data not shown) proved efficient in the detection of MNV strains in Maryland. Ten unique MNV strains (designated MNV NIH) were isolated from tissue and stool samples collected from asymptomatic laboratory mice that were housed in rooms with MNV-positive sentinel mice. The ten NIH murine norovirus strains clustered within Genogroup V, similar to all MNV strains characterized thus far. However, the strains fell into three distinct lineages within Genogroup V. Viruses isolated from mice within the same NIAID facility were distinct compared with those from mice in other facilities on campus. This observation suggests that strains are introduced independently from different sources as they are brought into each animal facility of the institute.

One MNV strain (NIH-2409) was selected for additional analyses in order to identify mutations in the genome involved in cell culture adaptation. Unlike MNV-1, which was highly cytopathic upon its initial isolation in cell culture [@pone.0021435-Wobus1], strain MNV NIH-2409 did not cause visible CPE in early passages. Interestingly, a single amino acid change was detected in the NS4 ("3A-like") protein following adaptation. Serine was the predominant amino acid at residue 721 in viral RNA purified from the original lymph node tissue, but alanine was the predominant amino acid residue after passage and plaque purification. This variation was similar in location to an amino acid residue (position 716) that changed from valine to isoleucine in NS4 of the MNV-1 strain following passage in RAW264.7 cells [@pone.0021435-Wobus1]. The function of the NS4 protein has not been determined, but it is likely that this protein may play a role in interactions with host cells. The majority of the synonymous (silent) nucleotide mutations during cell culture passage occurred in ORF1 and ORF2 in both NIH-2409 and MNV-1. Strain NIH-2409 showed no changes in ORF3 during serial passage, while MNV-1 demonstrated one silent change (nt 6770) during passage and plaque purification.

It is not clear when MNV was introduced into laboratory mice, and whether such strains circulate in wild mice. Recent studies of experimental mouse models found that the presence of MNV did not affect the immune response and recovery from Friend retrovirus [@pone.0021435-Ammann1], or the development of adaptive immunity to vaccinia virus and influenza virus [@pone.0021435-Hensley1]. Murine norovirus did not affect experimental outcomes from murine cytomegalovirus infection, although there was a decreased CD8 T cell response [@pone.0021435-Doom1]. However, the presence of MNV did increased the length of time have an effect on parvovirus was shedding in Balb/c mice [@pone.0021435-Compton1] and concerns have been raised for its effect in other murine disease models [@pone.0021435-Achard1], [@pone.0021435-Lencioni1], [@pone.0021435-Paik1]. Sequence analysis of the new MNV NIH strains described in this study contributes to the growing database of genomic norovirus sequences. Continued analysis of the molecular epidemiology of these viruses should give insight into their natural history and evolution in mice.

Materials and Methods {#s4}
=====================

Cells and viruses {#s4a}
-----------------

The murine macrophage-like cell line RAW264.7 was obtained from American Type Culture Collection (Manassas, VA). The cells were grown in Dulbecco\'s Modified Eagle\'s Medium (DMEM) supplemented with penicillin (250 units/ml), streptomycin (250 µg/ml), 1% glutamine, and 10% heat-inactivated fetal calf serum. Murine norovirus strain MNV-1 [@pone.0021435-Karst1] was a gift of Dr. Herbert Virgin, Washington University, Saint Louis, MO. Mesenteric lymph node (MLN), hepatic, spleen or duodenal tissues and fecal samples were collected from mice housed in three different NIAID animal facilities on the NIH, Bethesda, Maryland campus [@pone.0021435-Perdue1] ([Table 1](#pone-0021435-t001){ref-type="table"}) under a protocol approved by the NIAID Animal Care and Use Committee. Sentinel mice in these facilities were routinely monitored for serological evidence of infection with several agents, including MNV, and all three facilities reported MNV antibody-positive sentinel mice. Fifty µl of the filtered tissue or fecal suspension was added to a RAW264.7 cell monolayer seeded in one well of a 6-well tissue culture plate (Costar, Corning Inc., Corning, NY), after which the cells were incubated for 5--7 days at 37°C. Cells were then frozen and thawed and 50 µl of the resultant suspension was used to infect a new RAW264.7 cell monolayer. The material was passed between 2 and 7 times, depending on the amount of associated CPE. Fluid from the final passage was collected and subjected to three rounds of plaque-purification. A plaque from the third purification was isolated and amplified to serve as a virus stock for sequence analysis of the complete genome.

Tissue culture adaptation of MNV strain NIH-2409 {#s4b}
------------------------------------------------

An MLN homogenate from mouse 2409 was added to RAW264.7 cells in two wells of a 6-well plate. The material from one well was passed three times in RAW264.7 cells as described above. The second well was fixed with methanol and the presence of MNV antigen after 7 days was examined by immunofluorescence assay as described below. Following pass 3 (P3), the isolated MNV strain, designated NIH-2409, was plaque-purified three times (3XPP). Briefly, a plaque was removed from the monolayer with a pipette tip, diluted in medium, and then subjected directly to a second plaque-purification. A second plaque was removed, diluted in medium, and subjected directly to a third plaque purification. The final isolated plaque was amplified in cells and the virus stock was designated 3XPP. The consensus sequence of the genome of the virus present in the original tissue (P0) was determined and compared to that of the virus obtained at P1, P2, and after three rounds of plaque purification (3XPP).

RNA extraction {#s4c}
--------------

Tissue samples were placed in 0.5 ml sterile, cold phosphate buffered saline (PBS) and disrupted on ice with either a Dounce homogenizer or an electric high shear tissue homogenizer (Omni International, Kennesaw, GA). Tissue suspensions were then stored at −70°C. Fecal pellets were added to PBS at a concentration of approximately 10% w/v in a sterile microfuge tube, followed by vortexing. The solid material in the feces was pelleted by low-speed centrifugation (10,000 rpm×10 minutes) in a tabletop microfuge and the clarified fecal suspension was filtered and transferred to a sterile microfuge tube. Viral RNA was extracted with the QIAamp Viral RNA mini kit (Qiagen, Valencia, CA) using a 100 µl aliquot of either the fecal or tissue suspension. The extracted RNA was eluted in 50 µl of RNase-free water and stored at −70C°.

Sequence analysis of RT-PCR products {#s4d}
------------------------------------

The purified RNA was amplified by RT-PCR with the One Step RT-PCR kit (Invitrogen, Carlsbad, CA) in a strategy that produced seven amplicons that were gel-purified and sequenced directly (primers for RT-PCR shown in [Table 3](#pone-0021435-t003){ref-type="table"}). Sequencing was performed with the BigDye Terminator v.3.1 cycle Sequencing Ready Reaction kit in an AB1 3100 Automated sequencer (Applied Biosystems, Foster City, CA). The precise ends of the genome were determined with the 5′ and 3′ Rapid Amplification of cDNA Ends (RACE) systems from Invitrogen.

10.1371/journal.pone.0021435.t003

###### Primer pairs used in the amplification of NIH murine norovirus genomes.

![](pone.0021435.t003){#pone-0021435-t003-3}

  --------------------------- ------------------------------------------------------------------------------------------------
  **Region 1**                
  MNV-1 BsmBl/T7pro/5′-endF    ATATATATATCGTCTCAAAATTCGTCTCACTGGTAATACGACTCACTATAGTGAAATGAGGATGGCAACGCCATCTTCTGCGCCCTCTGTGCGC
  MNV-1 n1139R                                              GCAAATTTGCCCATCTCTTGGGCGGCCTTCAGGGCC
  **Region 2**                
  NIH MNV-1n922F                                             GCATAGTCAATGCCCTGATTCTTCTTGCTGAGC
  NIH MNV-1n2615R (VPg)                                      CCCCCGGCCTCTCTTGTTCTTGCCCTTCTTGCTC
  **Region 3**                
  NIH MNV-1n2392F                                           GTGTCAGGAGGATCAAAGAGGCTCGCCTTCGCTGC
  NIH MNV-1n3734R                                           CGCGTGGCTCTGAATAGGGCTTGAGCTGGTCTCGC
  **Region 4**                
  NIH MNV-1n3394F                                        CAGGTGACTGTGGCTGCCCCTATGTCTACAAGAAGGGAAAC
  NIH MNV-1n4840R                                           GCAGGGCCATCAATTGGGAGGGTCTCTGAGCGTGTC
  **Region 5**                
  NIH MNV-1n4450F                                              GCCCCTGCACCACGCAGCTGAACAGCTTGG
  NIH MNV-1n5722R                                           CACGGGCAAGTCGACCATCCGGTAGATGGTTCTCTC
  **Region 6**                
  NIH MNV-1 n5332F                                        GCCCACCTCTCAGCCATGTACACCGGCTGGGTTGGGAAC
  NIH MNV-1n6733R                                           CGCCTGAAGGTTTTGGACATTTGAGATGGAATTGC
  **Region 7**                
  NIH-MNV n6427F                                          GTCTCCTGGTTCGCGTCTAACGCGTTCACCGTGCAGTCC
  NIH-MNV 3′/polyA R                                        TTTAAAATGCATCTAAATACTACCAAAAGAAAAGAG
  --------------------------- ------------------------------------------------------------------------------------------------

Phylogenetic analysis {#s4e}
---------------------

Multiple sequence alignments were generated with the ClustalW algorithm in the MacVector, Inc. (Cary, NC) software package. Phylogenetic relationships were inferred using the Neighbor-joining method [@pone.0021435-Saitou1], with the evolutionary distances computed by the Tamura-Nei method [@pone.0021435-Tamura1]. The statistical support for tree nodes was evaluated by bootstrap analysis (500 replicates) [@pone.0021435-Felsenstein1]. Evolutionary analyses were conducted with the MEGA software package [@pone.0021435-Tamura2].

qRT-PCR detection assay {#s4f}
-----------------------

A real-time qRT-PCR assay was adapted for the detection of MNV RNA [@pone.0021435-Ammann1], [@pone.0021435-Bok1]. Briefly, a forward primer 5′-AATCTATGCGCCTGGTTTGC-3′ and a reverse primer 5′-CTCATCACCCGGGCTGTT-3′ were employed to amplify a region of the genome corresponding to nucleotides (nt) 5585--5646. A Taqman probe with the sequence 5′-CACGCCACTCCGC-3′ (corresponding to nt 5613--5625 of the MNV NIH-2409 genome) was generated with FAM dye linked to the 5′-end and BHQ dye at the 3′-end. Five µl of RNA were added to an RT-PCR mix (Brilliant II qRT-PCR core reagent kit, Stratagene, La Jolla, CA). The reaction was then incubated at 45°C for 30 min, 95°C for 10 min, followed by 45 cycles at 95°C for 30 sec, 50°C for 1 min and 72°C for 30 sec in an ABI 7900 HT instrument (Applied Biosystems). Each sample was tested in duplicate and an appropriate triplicate standard curve for absolute quantification was included in each run.

Immunofluorescence {#s4g}
------------------

RAW264.7 cells were infected with virus and incubated 7 days before fixation with cold methanol (100%). The methanol was removed and the cells were rinsed with PBS, pH 7.4. Hyperimmune serum raised in a guinea pig against recombinant MNV-1 VP1 [@pone.0021435-Ward1] was added at a 1∶100 dilution and incubated at 37°C for one hour. The wells were then rinsed three times with PBS, and affinity purified goat antibodies specific for guinea pig immunoglobulin G (IgG) (ICN Biomedicals, Aurora, OH) and conjugated to fluorescein isothiocyanate were added at a 1∶20 dilution to detect binding of the primary antibody.

Supporting Information {#s5}
======================

###### 

Murine norovirus strains included in phylogenetic analysis and their GenBank accession numbers are shown.

(XLSX)

###### 

Click here for additional data file.
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